The effect of tamsulosin and hydrochlorothiazide on stone excretion

The effect of tamsulosin, hydrochlorothiazide or concomitant use of both in increasing the risk of stone excretion after ESWL Stones smaller than 2 cm Upper ureter

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200704047998N1

Enrollment

240

Registered

2020-11-17

Start date

2019-05-22

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal stone. Calculus of ureter

Interventions

Intervention 1: The first group was treated with tamsulosin (0.4 mg / day, manufactured by Daru Pakhsh Company, Tehran, Iran). Patients were followed up for 3 months and asked about stone removal, num

Eligibility

Sex/Gender

All

Age

1 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients with ureteral stones below 2 cm are placed under a crusher

Exclusion criteria

Exclusion criteria: Stone above 2 cm upper ureter Severe and moderate hydronephrosis

Design outcomes

Primary

Measure	Time frame
Stone passage. Timepoint: Immediately .A week. One Month . three months. Method of measurement: Patient history for stone removal.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehnam Salehi

Iran University of Medical Sciences

Dr.behnam.salehi68@gmail.com+98 21 81161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026